StockOtters
StockOttersSupply Chain Map
HLB Pharmaceutical Co., Ltd logo

HLB Pharmaceutical Co., Ltd

047920.KQ

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
103
Cost of Revenue
38
Gross Profit
65
Gross Margin
63.2%
Operating Income
1
Operating Margin
1.1%
Net Income
2
Net Margin
1.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
5
EBITDA Margin
5.0%

2023

12/31/2023

Revenue
102
Cost of Revenue
40
Gross Profit
62
Gross Margin
61.0%
Operating Income
-15
Operating Margin
-14.4%
Net Income
-15
Net Margin
-14.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-2
EBITDA Margin
-1.5%

2022

12/31/2022

Revenue
81
Cost of Revenue
33
Gross Profit
48
Gross Margin
59.2%
Operating Income
-5
Operating Margin
-6.5%
Net Income
-9
Net Margin
-11.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-1
EBITDA Margin
-1.3%

2021

12/31/2021

Revenue
47
Cost of Revenue
21
Gross Profit
26
Gross Margin
55.6%
Operating Income
0
Operating Margin
0.4%
Net Income
-10
Net Margin
-21.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
6
EBITDA Margin
13.2%

2020

12/31/2020

Revenue
30
Cost of Revenue
14
Gross Profit
16
Gross Margin
53.9%
Operating Income
0
Operating Margin
1.6%
Net Income
-56
Net Margin
-184.5%
EPS (Basic)
$-4.00
EPS (Diluted)
$-4.00
EBITDA
-58
EBITDA Margin
-191.7%